001     272980
005     20250127091414.0
024 7 _ |a pmc:PMC11574007
|2 pmc
024 7 _ |a 10.1038/s41467-024-52937-8
|2 doi
024 7 _ |a pmid:39557867
|2 pmid
024 7 _ |a altmetric:170637821
|2 altmetric
037 _ _ |a DZNE-2024-01359
041 _ _ |a English
082 _ _ |a 500
100 1 _ |a Hofmann, Anna
|0 P:(DE-2719)2814244
|b 0
|e First author
|u dzne
245 _ _ |a Comparative neurofilament light chain trajectories in CSF and plasma in autosomal dominant Alzheimer's disease.
260 _ _ |a [London]
|c 2024
|b Nature Publishing Group UK
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1733132139_30589
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Disease-modifying therapies for Alzheimer's disease (AD) are likely to be most beneficial when initiated in the presymptomatic phase. To track the benefit of such interventions, fluid biomarkers are of great importance, with neurofilament light chain protein (NfL) showing promise for monitoring neurodegeneration and predicting cognitive outcomes. Here, we update and complement previous findings from the Dominantly Inherited Alzheimer Network Observational Study by using matched cross-sectional and longitudinal cerebrospinal fluid (CSF) and plasma samples from 567 individuals, allowing timely comparative analyses of CSF and blood trajectories across the entire disease spectrum. CSF and plasma trajectories were similar at presymptomatic stages, discriminating mutation carriers from non-carrier controls 10-20 years before the estimated onset of clinical symptoms, depending on the statistical model used. However, after symptom onset the rate of change in CSF NfL continued to increase steadily, whereas the rate of change in plasma NfL leveled off. Both plasma and CSF NfL changes were associated with grey-matter atrophy, but not with Aβ-PET changes, supporting a temporal decoupling of Aβ deposition and neurodegeneration. These observations support NfL in both CSF and blood as an early marker of neurodegeneration but suggest that NfL measured in the CSF may be better suited for monitoring clinical trial outcomes in symptomatic AD patients.
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 1
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a Neurofilament Proteins
|2 NLM Chemicals
650 _ 7 |a Biomarkers
|2 NLM Chemicals
650 _ 7 |a neurofilament protein L
|2 NLM Chemicals
650 _ 7 |a Amyloid beta-Peptides
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Alzheimer Disease: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Alzheimer Disease: blood
|2 MeSH
650 _ 2 |a Alzheimer Disease: genetics
|2 MeSH
650 _ 2 |a Alzheimer Disease: diagnosis
|2 MeSH
650 _ 2 |a Neurofilament Proteins: blood
|2 MeSH
650 _ 2 |a Neurofilament Proteins: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Biomarkers: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Biomarkers: blood
|2 MeSH
650 _ 2 |a Middle Aged
|2 MeSH
650 _ 2 |a Cross-Sectional Studies
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Longitudinal Studies
|2 MeSH
650 _ 2 |a Amyloid beta-Peptides: cerebrospinal fluid
|2 MeSH
650 _ 2 |a Amyloid beta-Peptides: blood
|2 MeSH
650 _ 2 |a Atrophy
|2 MeSH
650 _ 2 |a Gray Matter: pathology
|2 MeSH
650 _ 2 |a Gray Matter: diagnostic imaging
|2 MeSH
650 _ 2 |a Aged
|2 MeSH
650 _ 2 |a Positron-Emission Tomography
|2 MeSH
650 _ 2 |a Disease Progression
|2 MeSH
693 _ _ |0 EXP:(DE-2719)DIAN-20090101
|5 EXP:(DE-2719)DIAN-20090101
|e Longitudinal Study on Dominantly Inherited Alzheimer's Disease
|x 0
700 1 _ |a Häsler, Lisa M
|0 P:(DE-2719)2811581
|b 1
|u dzne
700 1 _ |a Lambert, Marius
|0 P:(DE-2719)2810762
|b 2
|u dzne
700 1 _ |a Kaeser, Stephan
|0 P:(DE-2719)9000387
|b 3
|u dzne
700 1 _ |a Gräber-Sultan, Susanne
|0 P:(DE-2719)2810662
|b 4
|u dzne
700 1 _ |a Obermüller, Ulrike
|0 P:(DE-2719)2814201
|b 5
|u dzne
700 1 _ |a Kuder-Buletta, Elke
|0 P:(DE-2719)2810869
|b 6
|u dzne
700 1 _ |a la Fougère, Christian
|0 P:(DE-2719)9000177
|b 7
700 1 _ |a Laske, Christoph
|0 P:(DE-2719)2000055
|b 8
|u dzne
700 1 _ |a Vöglein, Jonathan
|0 P:(DE-2719)2811820
|b 9
700 1 _ |a Levin, Johannes
|0 P:(DE-2719)2811659
|b 10
700 1 _ |a Fox, Nick C
|0 0000-0002-6660-657X
|b 11
700 1 _ |a Ryan, Natalie S
|b 12
700 1 _ |a Zetterberg, Henrik
|0 0000-0003-3930-4354
|b 13
700 1 _ |a Llibre-Guerra, Jorge J
|0 0000-0002-2137-7750
|b 14
700 1 _ |a Perrin, Richard J
|0 0000-0002-3443-7716
|b 15
700 1 _ |a Ibanez, Laura
|b 16
700 1 _ |a Schofield, Peter R
|0 0000-0003-2967-9662
|b 17
700 1 _ |a Brooks, William S
|0 0000-0001-8603-4233
|b 18
700 1 _ |a Day, Gregory S
|0 0000-0001-5133-5538
|b 19
700 1 _ |a Farlow, Martin R
|0 0000-0001-7897-5471
|b 20
700 1 _ |a Allegri, Ricardo F
|0 0000-0001-7166-1234
|b 21
700 1 _ |a Chrem Mendez, Patricio
|b 22
700 1 _ |a Ikeuchi, Takeshi
|0 0000-0001-8828-8085
|b 23
700 1 _ |a Kasuga, Kensaku
|0 0000-0002-2178-0769
|b 24
700 1 _ |a Lee, Jae-Hong
|0 P:(DE-HGF)0
|b 25
700 1 _ |a Roh, Jee Hoon
|0 0000-0002-3243-0529
|b 26
700 1 _ |a Mori, Hiroshi
|b 27
700 1 _ |a Lopera, Francisco
|0 0000-0003-3986-1484
|b 28
700 1 _ |a Bateman, Randall J
|0 0000-0002-7729-1702
|b 29
700 1 _ |a McDade, Eric
|b 30
700 1 _ |a Gordon, Brian A
|0 0000-0003-2109-2955
|b 31
700 1 _ |a Chhatwal, Jasmeer P
|0 0000-0002-7792-1698
|b 32
700 1 _ |a Jucker, Mathias
|0 P:(DE-2719)2000010
|b 33
700 1 _ |a Schultz, Stephanie A
|0 0000-0001-8460-4415
|b 34
700 1 _ |a Network, Dominantly Inherited Alzheimer
|b 35
|e Collaboration Author
700 1 _ |a Aguillon, David
|b 36
|e Contributor
700 1 _ |a Aschenbrenner, Andrew J
|b 37
|e Contributor
700 1 _ |a Baker, Bryce
|b 38
|e Contributor
700 1 _ |a Barthelemy, Nicolas
|b 39
|e Contributor
700 1 _ |a Bateman, Randall
|b 40
|e Contributor
700 1 _ |a Bechara, Jacob A
|b 41
|e Contributor
700 1 _ |a Benzinger, Tammie
|b 42
|e Contributor
700 1 _ |a Berman, Sarah B
|b 43
|e Contributor
700 1 _ |a Cash, David M
|b 44
|e Contributor
700 1 _ |a Chen, Allison
|b 45
|e Contributor
700 1 _ |a Chen, Charles
|b 46
|e Contributor
700 1 _ |a Chhatwal Chhatwal, Jasmeer P
|b 47
|e Contributor
700 1 _ |a Mendez, Patricio Chrem
|b 48
|e Contributor
700 1 _ |a Courtney, Laura
|b 49
|e Contributor
700 1 _ |a Cruchaga, Carlos
|b 50
|e Contributor
700 1 _ |a Daniels, Alisha J
|b 51
|e Contributor
700 1 _ |a Day, Gregory S
|b 52
|e Contributor
700 1 _ |a Fagan, Anne M
|b 53
|e Contributor
700 1 _ |a Farlow, Martin
|b 54
|e Contributor
700 1 _ |a Flores, Shaney
|b 55
|e Contributor
700 1 _ |a Franklin, Erin
|b 56
|e Contributor
700 1 _ |a Goate, Alison M
|b 57
|e Contributor
700 1 _ |a Gräber-Sultan, Susanne
|0 P:(DE-2719)2810662
|b 58
|e Contributor
|u dzne
700 1 _ |a Graff-Radford, Neill R
|b 59
|e Contributor
700 1 _ |a Gremminger, Emily
|b 60
|e Contributor
700 1 _ |a Hassenstab, Jason
|b 61
|e Contributor
700 1 _ |a Herries, Elizabeth
|b 62
|e Contributor
700 1 _ |a Holtzman, David M
|b 63
|e Contributor
700 1 _ |a Hornbeck, Russ
|b 64
|e Contributor
700 1 _ |a Huey, Edward D
|b 65
|e Contributor
700 1 _ |a Ikonomovic, Snezana
|b 66
|e Contributor
700 1 _ |a Jackson, Kelley
|b 67
|e Contributor
700 1 _ |a Jarman, Steve
|b 68
|e Contributor
700 1 _ |a Jerome, Gina
|b 69
|e Contributor
700 1 _ |a Johnson, Erik C B
|b 70
|e Contributor
700 1 _ |a Joseph-Mathurin, Nelly
|b 71
|e Contributor
700 1 _ |a Karch, Celeste M
|b 72
|e Contributor
700 1 _ |a Keefe, Sarah
|b 73
|e Contributor
700 1 _ |a Koudelis, Deborah
|b 74
|e Contributor
700 1 _ |a Laske, Christoph
|0 P:(DE-2719)2000055
|b 75
|e Contributor
|u dzne
700 1 _ |a Leon, Yudy Milena
|b 76
|e Contributor
700 1 _ |a Levey, Allan I
|b 77
|e Contributor
700 1 _ |a Li, Yan
|b 78
|e Contributor
700 1 _ |a Lu, Ruijin
|b 79
|e Contributor
700 1 _ |a Marsh, Jacob
|b 80
|e Contributor
700 1 _ |a Martins, Ralph
|b 81
|e Contributor
700 1 _ |a Massoumzadeh, Parinaz
|b 82
|e Contributor
700 1 _ |a Masters, Colin
|b 83
|e Contributor
700 1 _ |a McCullough, Austin
|b 84
|e Contributor
700 1 _ |a McDade, Eric
|b 85
|e Contributor
700 1 _ |a McKay, Nicole
|b 86
|e Contributor
700 1 _ |a Minton, Matthew
|b 87
|e Contributor
700 1 _ |a Morris, John C
|b 88
|e Contributor
700 1 _ |a Nadkarni, Neelesh K
|b 89
|e Contributor
700 1 _ |a Nicklaus, Joyce
|b 90
|e Contributor
700 1 _ |a Niimi, Yoshiki
|b 91
|e Contributor
700 1 _ |a Noble, James M
|b 92
|e Contributor
700 1 _ |a Obermueller, Ulrike
|b 93
|e Contributor
700 1 _ |a Picarello, Danielle M
|b 94
|e Contributor
700 1 _ |a Pulizos, Christine
|b 95
|e Contributor
700 1 _ |a Ramirez, Laura
|b 96
|e Contributor
700 1 _ |a Renton, Alan E
|b 97
|e Contributor
700 1 _ |a Ringman, John
|b 98
|e Contributor
700 1 _ |a Rizzo, Jacqueline
|b 99
|e Contributor
700 1 _ |a Rödenbeck, Yvonne Esther
|0 P:(DE-2719)2810668
|b 100
|e Contributor
|u dzne
700 1 _ |a Rosa-Neto, Pedro
|b 101
|e Contributor
700 1 _ |a Sabaredzovic, Edita
|b 102
|e Contributor
700 1 _ |a Salloway, Stephen
|b 103
|e Contributor
700 1 _ |a Sanchez-Valle, Raquel
|b 104
|e Contributor
700 1 _ |a Scott, Jalen
|b 105
|e Contributor
700 1 _ |a Seyfried, Nicholas T
|b 106
|e Contributor
700 1 _ |a Simmons, Ashlee
|b 107
|e Contributor
700 1 _ |a Smith, Jennifer
|b 108
|e Contributor
700 1 _ |a Smith, Hunter
|b 109
|e Contributor
700 1 _ |a Stauber, Jennifer
|b 110
|e Contributor
700 1 _ |a Stout, Sarah
|b 111
|e Contributor
700 1 _ |a Supnet-Bell, Charlene
|b 112
|e Contributor
700 1 _ |a Surace, Ezequiel
|b 113
|e Contributor
700 1 _ |a Vazquez, Silvia
|b 114
|e Contributor
700 1 _ |a Vöglein, Jonathan
|0 P:(DE-2719)2811820
|b 115
|e Contributor
|u dzne
700 1 _ |a Wang, Guoqiao
|b 116
|e Contributor
700 1 _ |a Wang, Qing
|0 P:(DE-HGF)0
|b 117
|e Contributor
700 1 _ |a Xiong, Chengie
|b 118
|e Contributor
700 1 _ |a Xu, Xiong
|b 119
|e Contributor
700 1 _ |a Xu, Jinbin
|b 120
|e Contributor
773 _ _ |a 10.1038/s41467-024-52937-8
|g Vol. 15, no. 1, p. 9982
|0 PERI:(DE-600)2553671-0
|n 1
|p 9982
|t Nature Communications
|v 15
|y 2024
|x 2041-1723
856 4 _ |u https://pub.dzne.de/record/272980/files/DZNE-2024-01359%20SUP.zip
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/272980/files/DZNE-2024-01359.pdf
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/272980/files/DZNE-2024-01359.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:272980
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2814244
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 1
|6 P:(DE-2719)2811581
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)2810762
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 3
|6 P:(DE-2719)9000387
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2810662
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2814201
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)2810869
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 7
|6 P:(DE-2719)9000177
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)2000055
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)2811820
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2811659
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 33
|6 P:(DE-2719)2000010
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 58
|6 P:(DE-2719)2810662
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 75
|6 P:(DE-2719)2000055
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 100
|6 P:(DE-2719)2810668
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 115
|6 P:(DE-2719)2811820
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 1
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1040
|2 StatID
|b Zoological Record
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-05-02T09:09:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-08-29
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2023-08-29
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1150
|2 StatID
|b Current Contents - Physical, Chemical and Earth Sciences
|d 2023-08-29
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-08-29
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NAT COMMUN : 2022
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-05-02T09:09:09Z
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-08-29
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a IF >= 15
|0 StatID:(DE-HGF)9915
|2 StatID
|b NAT COMMUN : 2022
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-08-29
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2023-05-02T09:09:09Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-08-29
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2023-08-29
920 1 _ |0 I:(DE-2719)1210001
|k AG Jucker
|l Cell Biology of Neurological Diseases
|x 0
920 1 _ |0 I:(DE-2719)1210000
|k AG Gasser
|l Parkinson Genetics
|x 1
920 1 _ |0 I:(DE-2719)1111015
|k Clinical Research (Munich)
|l Clinical Research (Munich)
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1210001
980 _ _ |a I:(DE-2719)1210000
980 _ _ |a I:(DE-2719)1111015
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21